Global Oral Anticoagulants Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of Oral Anticoagulants will have significant change from previous year. According to our (LP Information) latest study, the global Oral Anticoagulants market size is USD million in 2022 from USD 14210 million in 2021, with a change of % between 2021 and 2022. The global Oral Anticoagulants market size will reach USD 23350 million in 2028, growing at a CAGR of 7.4% over the analysis period.
The United States Oral Anticoagulants market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Oral Anticoagulants market, reaching US$ million by the year 2028. As for the Europe Oral Anticoagulants landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Oral Anticoagulants players cover Johnson & Johnson, Bristol-Myers Squibb, Boehringer Ingelheim, and Sanofi, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Oral Anticoagulants market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
As the global economy mends, the 2021 growth of Oral Anticoagulants will have significant change from previous year. According to our (LP Information) latest study, the global Oral Anticoagulants market size is USD million in 2022 from USD 14210 million in 2021, with a change of % between 2021 and 2022. The global Oral Anticoagulants market size will reach USD 23350 million in 2028, growing at a CAGR of 7.4% over the analysis period.
The United States Oral Anticoagulants market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Oral Anticoagulants market, reaching US$ million by the year 2028. As for the Europe Oral Anticoagulants landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Oral Anticoagulants players cover Johnson & Johnson, Bristol-Myers Squibb, Boehringer Ingelheim, and Sanofi, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Oral Anticoagulants market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
- Direct Thrombin Inhibitors
- Direct Factor Xa Inhibitors
- Deep Vein Thrombosis (DVT)
- Pulmonary Embolism
- Acute Coronary Syndrome
- Hemodialysis
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Johnson & Johnson
- Bristol-Myers Squibb
- Boehringer Ingelheim
- Sanofi
- Daiichi Sankyo
- Armatheon
- Aspen
- AstraZeneca
- Bayer
- Cellceutix
- Cosmo Pharmaceuticals
- CSL Behring
- Eisai
- GSK
- Marathon Pharmaceuticals
- Ockham Biotech
- Perosphere
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oral Anticoagulants Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Oral Anticoagulants by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Oral Anticoagulants by Country/Region, 2017, 2022 & 2028
2.2 Oral Anticoagulants Segment by Type
2.2.1 Direct Thrombin Inhibitors
2.2.2 Direct Factor Xa Inhibitors
2.3 Oral Anticoagulants Sales by Type
2.3.1 Global Oral Anticoagulants Sales Market Share by Type (2017-2022)
2.3.2 Global Oral Anticoagulants Revenue and Market Share by Type (2017-2022)
2.3.3 Global Oral Anticoagulants Sale Price by Type (2017-2022)
2.4 Oral Anticoagulants Segment by Application
2.4.1 Deep Vein Thrombosis (DVT)
2.4.2 Pulmonary Embolism
2.4.3 Acute Coronary Syndrome
2.4.4 Hemodialysis
2.4.5 Others
2.5 Oral Anticoagulants Sales by Application
2.5.1 Global Oral Anticoagulants Sale Market Share by Application (2017-2022)
2.5.2 Global Oral Anticoagulants Revenue and Market Share by Application (2017-2022)
2.5.3 Global Oral Anticoagulants Sale Price by Application (2017-2022)
3 GLOBAL ORAL ANTICOAGULANTS BY COMPANY
3.1 Global Oral Anticoagulants Breakdown Data by Company
3.1.1 Global Oral Anticoagulants Annual Sales by Company (2020-2022)
3.1.2 Global Oral Anticoagulants Sales Market Share by Company (2020-2022)
3.2 Global Oral Anticoagulants Annual Revenue by Company (2020-2022)
3.2.1 Global Oral Anticoagulants Revenue by Company (2020-2022)
3.2.2 Global Oral Anticoagulants Revenue Market Share by Company (2020-2022)
3.3 Global Oral Anticoagulants Sale Price by Company
3.4 Key Manufacturers Oral Anticoagulants Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oral Anticoagulants Product Location Distribution
3.4.2 Players Oral Anticoagulants Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ORAL ANTICOAGULANTS BY GEOGRAPHIC REGION
4.1 World Historic Oral Anticoagulants Market Size by Geographic Region (2017-2022)
4.1.1 Global Oral Anticoagulants Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Oral Anticoagulants Annual Revenue by Geographic Region
4.2 World Historic Oral Anticoagulants Market Size by Country/Region (2017-2022)
4.2.1 Global Oral Anticoagulants Annual Sales by Country/Region (2017-2022)
4.2.2 Global Oral Anticoagulants Annual Revenue by Country/Region
4.3 Americas Oral Anticoagulants Sales Growth
4.4 APAC Oral Anticoagulants Sales Growth
4.5 Europe Oral Anticoagulants Sales Growth
4.6 Middle East & Africa Oral Anticoagulants Sales Growth
5 AMERICAS
5.1 Americas Oral Anticoagulants Sales by Country
5.1.1 Americas Oral Anticoagulants Sales by Country (2017-2022)
5.1.2 Americas Oral Anticoagulants Revenue by Country (2017-2022)
5.2 Americas Oral Anticoagulants Sales by Type
5.3 Americas Oral Anticoagulants Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral Anticoagulants Sales by Region
6.1.1 APAC Oral Anticoagulants Sales by Region (2017-2022)
6.1.2 APAC Oral Anticoagulants Revenue by Region (2017-2022)
6.2 APAC Oral Anticoagulants Sales by Type
6.3 APAC Oral Anticoagulants Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Oral Anticoagulants by Country
7.1.1 Europe Oral Anticoagulants Sales by Country (2017-2022)
7.1.2 Europe Oral Anticoagulants Revenue by Country (2017-2022)
7.2 Europe Oral Anticoagulants Sales by Type
7.3 Europe Oral Anticoagulants Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oral Anticoagulants by Country
8.1.1 Middle East & Africa Oral Anticoagulants Sales by Country (2017-2022)
8.1.2 Middle East & Africa Oral Anticoagulants Revenue by Country (2017-2022)
8.2 Middle East & Africa Oral Anticoagulants Sales by Type
8.3 Middle East & Africa Oral Anticoagulants Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oral Anticoagulants
10.3 Manufacturing Process Analysis of Oral Anticoagulants
10.4 Industry Chain Structure of Oral Anticoagulants
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oral Anticoagulants Distributors
11.3 Oral Anticoagulants Customer
12 WORLD FORECAST REVIEW FOR ORAL ANTICOAGULANTS BY GEOGRAPHIC REGION
12.1 Global Oral Anticoagulants Market Size Forecast by Region
12.1.1 Global Oral Anticoagulants Forecast by Region (2023-2028)
12.1.2 Global Oral Anticoagulants Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Oral Anticoagulants Forecast by Type
12.7 Global Oral Anticoagulants Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Johnson & Johnson
13.1.1 Johnson & Johnson Company Information
13.1.2 Johnson & Johnson Oral Anticoagulants Product Offered
13.1.3 Johnson & Johnson Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Johnson & Johnson Main Business Overview
13.1.5 Johnson & Johnson Latest Developments
13.2 Bristol-Myers Squibb
13.2.1 Bristol-Myers Squibb Company Information
13.2.2 Bristol-Myers Squibb Oral Anticoagulants Product Offered
13.2.3 Bristol-Myers Squibb Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Bristol-Myers Squibb Main Business Overview
13.2.5 Bristol-Myers Squibb Latest Developments
13.3 Boehringer Ingelheim
13.3.1 Boehringer Ingelheim Company Information
13.3.2 Boehringer Ingelheim Oral Anticoagulants Product Offered
13.3.3 Boehringer Ingelheim Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Boehringer Ingelheim Main Business Overview
13.3.5 Boehringer Ingelheim Latest Developments
13.4 Sanofi
13.4.1 Sanofi Company Information
13.4.2 Sanofi Oral Anticoagulants Product Offered
13.4.3 Sanofi Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Sanofi Main Business Overview
13.4.5 Sanofi Latest Developments
13.5 Daiichi Sankyo
13.5.1 Daiichi Sankyo Company Information
13.5.2 Daiichi Sankyo Oral Anticoagulants Product Offered
13.5.3 Daiichi Sankyo Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Daiichi Sankyo Main Business Overview
13.5.5 Daiichi Sankyo Latest Developments
13.6 Armatheon
13.6.1 Armatheon Company Information
13.6.2 Armatheon Oral Anticoagulants Product Offered
13.6.3 Armatheon Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Armatheon Main Business Overview
13.6.5 Armatheon Latest Developments
13.7 Aspen
13.7.1 Aspen Company Information
13.7.2 Aspen Oral Anticoagulants Product Offered
13.7.3 Aspen Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Aspen Main Business Overview
13.7.5 Aspen Latest Developments
13.8 AstraZeneca
13.8.1 AstraZeneca Company Information
13.8.2 AstraZeneca Oral Anticoagulants Product Offered
13.8.3 AstraZeneca Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 AstraZeneca Main Business Overview
13.8.5 AstraZeneca Latest Developments
13.9 Bayer
13.9.1 Bayer Company Information
13.9.2 Bayer Oral Anticoagulants Product Offered
13.9.3 Bayer Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Bayer Main Business Overview
13.9.5 Bayer Latest Developments
13.10 Cellceutix
13.10.1 Cellceutix Company Information
13.10.2 Cellceutix Oral Anticoagulants Product Offered
13.10.3 Cellceutix Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Cellceutix Main Business Overview
13.10.5 Cellceutix Latest Developments
13.11 Cosmo Pharmaceuticals
13.11.1 Cosmo Pharmaceuticals Company Information
13.11.2 Cosmo Pharmaceuticals Oral Anticoagulants Product Offered
13.11.3 Cosmo Pharmaceuticals Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Cosmo Pharmaceuticals Main Business Overview
13.11.5 Cosmo Pharmaceuticals Latest Developments
13.12 CSL Behring
13.12.1 CSL Behring Company Information
13.12.2 CSL Behring Oral Anticoagulants Product Offered
13.12.3 CSL Behring Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 CSL Behring Main Business Overview
13.12.5 CSL Behring Latest Developments
13.13 Eisai
13.13.1 Eisai Company Information
13.13.2 Eisai Oral Anticoagulants Product Offered
13.13.3 Eisai Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Eisai Main Business Overview
13.13.5 Eisai Latest Developments
13.14 GSK
13.14.1 GSK Company Information
13.14.2 GSK Oral Anticoagulants Product Offered
13.14.3 GSK Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 GSK Main Business Overview
13.14.5 GSK Latest Developments
13.15 Marathon Pharmaceuticals
13.15.1 Marathon Pharmaceuticals Company Information
13.15.2 Marathon Pharmaceuticals Oral Anticoagulants Product Offered
13.15.3 Marathon Pharmaceuticals Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Marathon Pharmaceuticals Main Business Overview
13.15.5 Marathon Pharmaceuticals Latest Developments
13.16 Ockham Biotech
13.16.1 Ockham Biotech Company Information
13.16.2 Ockham Biotech Oral Anticoagulants Product Offered
13.16.3 Ockham Biotech Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Ockham Biotech Main Business Overview
13.16.5 Ockham Biotech Latest Developments
13.17 Perosphere
13.17.1 Perosphere Company Information
13.17.2 Perosphere Oral Anticoagulants Product Offered
13.17.3 Perosphere Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Perosphere Main Business Overview
13.17.5 Perosphere Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oral Anticoagulants Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Oral Anticoagulants by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Oral Anticoagulants by Country/Region, 2017, 2022 & 2028
2.2 Oral Anticoagulants Segment by Type
2.2.1 Direct Thrombin Inhibitors
2.2.2 Direct Factor Xa Inhibitors
2.3 Oral Anticoagulants Sales by Type
2.3.1 Global Oral Anticoagulants Sales Market Share by Type (2017-2022)
2.3.2 Global Oral Anticoagulants Revenue and Market Share by Type (2017-2022)
2.3.3 Global Oral Anticoagulants Sale Price by Type (2017-2022)
2.4 Oral Anticoagulants Segment by Application
2.4.1 Deep Vein Thrombosis (DVT)
2.4.2 Pulmonary Embolism
2.4.3 Acute Coronary Syndrome
2.4.4 Hemodialysis
2.4.5 Others
2.5 Oral Anticoagulants Sales by Application
2.5.1 Global Oral Anticoagulants Sale Market Share by Application (2017-2022)
2.5.2 Global Oral Anticoagulants Revenue and Market Share by Application (2017-2022)
2.5.3 Global Oral Anticoagulants Sale Price by Application (2017-2022)
3 GLOBAL ORAL ANTICOAGULANTS BY COMPANY
3.1 Global Oral Anticoagulants Breakdown Data by Company
3.1.1 Global Oral Anticoagulants Annual Sales by Company (2020-2022)
3.1.2 Global Oral Anticoagulants Sales Market Share by Company (2020-2022)
3.2 Global Oral Anticoagulants Annual Revenue by Company (2020-2022)
3.2.1 Global Oral Anticoagulants Revenue by Company (2020-2022)
3.2.2 Global Oral Anticoagulants Revenue Market Share by Company (2020-2022)
3.3 Global Oral Anticoagulants Sale Price by Company
3.4 Key Manufacturers Oral Anticoagulants Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oral Anticoagulants Product Location Distribution
3.4.2 Players Oral Anticoagulants Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ORAL ANTICOAGULANTS BY GEOGRAPHIC REGION
4.1 World Historic Oral Anticoagulants Market Size by Geographic Region (2017-2022)
4.1.1 Global Oral Anticoagulants Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Oral Anticoagulants Annual Revenue by Geographic Region
4.2 World Historic Oral Anticoagulants Market Size by Country/Region (2017-2022)
4.2.1 Global Oral Anticoagulants Annual Sales by Country/Region (2017-2022)
4.2.2 Global Oral Anticoagulants Annual Revenue by Country/Region
4.3 Americas Oral Anticoagulants Sales Growth
4.4 APAC Oral Anticoagulants Sales Growth
4.5 Europe Oral Anticoagulants Sales Growth
4.6 Middle East & Africa Oral Anticoagulants Sales Growth
5 AMERICAS
5.1 Americas Oral Anticoagulants Sales by Country
5.1.1 Americas Oral Anticoagulants Sales by Country (2017-2022)
5.1.2 Americas Oral Anticoagulants Revenue by Country (2017-2022)
5.2 Americas Oral Anticoagulants Sales by Type
5.3 Americas Oral Anticoagulants Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral Anticoagulants Sales by Region
6.1.1 APAC Oral Anticoagulants Sales by Region (2017-2022)
6.1.2 APAC Oral Anticoagulants Revenue by Region (2017-2022)
6.2 APAC Oral Anticoagulants Sales by Type
6.3 APAC Oral Anticoagulants Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Oral Anticoagulants by Country
7.1.1 Europe Oral Anticoagulants Sales by Country (2017-2022)
7.1.2 Europe Oral Anticoagulants Revenue by Country (2017-2022)
7.2 Europe Oral Anticoagulants Sales by Type
7.3 Europe Oral Anticoagulants Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oral Anticoagulants by Country
8.1.1 Middle East & Africa Oral Anticoagulants Sales by Country (2017-2022)
8.1.2 Middle East & Africa Oral Anticoagulants Revenue by Country (2017-2022)
8.2 Middle East & Africa Oral Anticoagulants Sales by Type
8.3 Middle East & Africa Oral Anticoagulants Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oral Anticoagulants
10.3 Manufacturing Process Analysis of Oral Anticoagulants
10.4 Industry Chain Structure of Oral Anticoagulants
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oral Anticoagulants Distributors
11.3 Oral Anticoagulants Customer
12 WORLD FORECAST REVIEW FOR ORAL ANTICOAGULANTS BY GEOGRAPHIC REGION
12.1 Global Oral Anticoagulants Market Size Forecast by Region
12.1.1 Global Oral Anticoagulants Forecast by Region (2023-2028)
12.1.2 Global Oral Anticoagulants Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Oral Anticoagulants Forecast by Type
12.7 Global Oral Anticoagulants Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Johnson & Johnson
13.1.1 Johnson & Johnson Company Information
13.1.2 Johnson & Johnson Oral Anticoagulants Product Offered
13.1.3 Johnson & Johnson Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Johnson & Johnson Main Business Overview
13.1.5 Johnson & Johnson Latest Developments
13.2 Bristol-Myers Squibb
13.2.1 Bristol-Myers Squibb Company Information
13.2.2 Bristol-Myers Squibb Oral Anticoagulants Product Offered
13.2.3 Bristol-Myers Squibb Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Bristol-Myers Squibb Main Business Overview
13.2.5 Bristol-Myers Squibb Latest Developments
13.3 Boehringer Ingelheim
13.3.1 Boehringer Ingelheim Company Information
13.3.2 Boehringer Ingelheim Oral Anticoagulants Product Offered
13.3.3 Boehringer Ingelheim Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Boehringer Ingelheim Main Business Overview
13.3.5 Boehringer Ingelheim Latest Developments
13.4 Sanofi
13.4.1 Sanofi Company Information
13.4.2 Sanofi Oral Anticoagulants Product Offered
13.4.3 Sanofi Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Sanofi Main Business Overview
13.4.5 Sanofi Latest Developments
13.5 Daiichi Sankyo
13.5.1 Daiichi Sankyo Company Information
13.5.2 Daiichi Sankyo Oral Anticoagulants Product Offered
13.5.3 Daiichi Sankyo Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Daiichi Sankyo Main Business Overview
13.5.5 Daiichi Sankyo Latest Developments
13.6 Armatheon
13.6.1 Armatheon Company Information
13.6.2 Armatheon Oral Anticoagulants Product Offered
13.6.3 Armatheon Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Armatheon Main Business Overview
13.6.5 Armatheon Latest Developments
13.7 Aspen
13.7.1 Aspen Company Information
13.7.2 Aspen Oral Anticoagulants Product Offered
13.7.3 Aspen Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Aspen Main Business Overview
13.7.5 Aspen Latest Developments
13.8 AstraZeneca
13.8.1 AstraZeneca Company Information
13.8.2 AstraZeneca Oral Anticoagulants Product Offered
13.8.3 AstraZeneca Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 AstraZeneca Main Business Overview
13.8.5 AstraZeneca Latest Developments
13.9 Bayer
13.9.1 Bayer Company Information
13.9.2 Bayer Oral Anticoagulants Product Offered
13.9.3 Bayer Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Bayer Main Business Overview
13.9.5 Bayer Latest Developments
13.10 Cellceutix
13.10.1 Cellceutix Company Information
13.10.2 Cellceutix Oral Anticoagulants Product Offered
13.10.3 Cellceutix Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Cellceutix Main Business Overview
13.10.5 Cellceutix Latest Developments
13.11 Cosmo Pharmaceuticals
13.11.1 Cosmo Pharmaceuticals Company Information
13.11.2 Cosmo Pharmaceuticals Oral Anticoagulants Product Offered
13.11.3 Cosmo Pharmaceuticals Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Cosmo Pharmaceuticals Main Business Overview
13.11.5 Cosmo Pharmaceuticals Latest Developments
13.12 CSL Behring
13.12.1 CSL Behring Company Information
13.12.2 CSL Behring Oral Anticoagulants Product Offered
13.12.3 CSL Behring Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 CSL Behring Main Business Overview
13.12.5 CSL Behring Latest Developments
13.13 Eisai
13.13.1 Eisai Company Information
13.13.2 Eisai Oral Anticoagulants Product Offered
13.13.3 Eisai Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Eisai Main Business Overview
13.13.5 Eisai Latest Developments
13.14 GSK
13.14.1 GSK Company Information
13.14.2 GSK Oral Anticoagulants Product Offered
13.14.3 GSK Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 GSK Main Business Overview
13.14.5 GSK Latest Developments
13.15 Marathon Pharmaceuticals
13.15.1 Marathon Pharmaceuticals Company Information
13.15.2 Marathon Pharmaceuticals Oral Anticoagulants Product Offered
13.15.3 Marathon Pharmaceuticals Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Marathon Pharmaceuticals Main Business Overview
13.15.5 Marathon Pharmaceuticals Latest Developments
13.16 Ockham Biotech
13.16.1 Ockham Biotech Company Information
13.16.2 Ockham Biotech Oral Anticoagulants Product Offered
13.16.3 Ockham Biotech Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Ockham Biotech Main Business Overview
13.16.5 Ockham Biotech Latest Developments
13.17 Perosphere
13.17.1 Perosphere Company Information
13.17.2 Perosphere Oral Anticoagulants Product Offered
13.17.3 Perosphere Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Perosphere Main Business Overview
13.17.5 Perosphere Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Oral Anticoagulants Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Oral Anticoagulants Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Direct Thrombin Inhibitors
Table 4. Major Players of Direct Factor Xa Inhibitors
Table 5. Global Oral Anticoagulants Sales by Type (2017-2022) & (K Units)
Table 6. Global Oral Anticoagulants Sales Market Share by Type (2017-2022)
Table 7. Global Oral Anticoagulants Revenue by Type (2017-2022) & ($ million)
Table 8. Global Oral Anticoagulants Revenue Market Share by Type (2017-2022)
Table 9. Global Oral Anticoagulants Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Oral Anticoagulants Sales by Application (2017-2022) & (K Units)
Table 11. Global Oral Anticoagulants Sales Market Share by Application (2017-2022)
Table 12. Global Oral Anticoagulants Revenue by Application (2017-2022)
Table 13. Global Oral Anticoagulants Revenue Market Share by Application (2017-2022)
Table 14. Global Oral Anticoagulants Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Oral Anticoagulants Sales by Company (2020-2022) & (K Units)
Table 16. Global Oral Anticoagulants Sales Market Share by Company (2020-2022)
Table 17. Global Oral Anticoagulants Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Oral Anticoagulants Revenue Market Share by Company (2020-2022)
Table 19. Global Oral Anticoagulants Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Oral Anticoagulants Producing Area Distribution and Sales Area
Table 21. Players Oral Anticoagulants Products Offered
Table 22. Oral Anticoagulants Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Oral Anticoagulants Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Oral Anticoagulants Sales Market Share Geographic Region (2017-2022)
Table 27. Global Oral Anticoagulants Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Oral Anticoagulants Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Oral Anticoagulants Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Oral Anticoagulants Sales Market Share by Country/Region (2017-2022)
Table 31. Global Oral Anticoagulants Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Oral Anticoagulants Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Oral Anticoagulants Sales by Country (2017-2022) & (K Units)
Table 34. Americas Oral Anticoagulants Sales Market Share by Country (2017-2022)
Table 35. Americas Oral Anticoagulants Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Oral Anticoagulants Revenue Market Share by Country (2017-2022)
Table 37. Americas Oral Anticoagulants Sales by Type (2017-2022) & (K Units)
Table 38. Americas Oral Anticoagulants Sales Market Share by Type (2017-2022)
Table 39. Americas Oral Anticoagulants Sales by Application (2017-2022) & (K Units)
Table 40. Americas Oral Anticoagulants Sales Market Share by Application (2017-2022)
Table 41. APAC Oral Anticoagulants Sales by Region (2017-2022) & (K Units)
Table 42. APAC Oral Anticoagulants Sales Market Share by Region (2017-2022)
Table 43. APAC Oral Anticoagulants Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Oral Anticoagulants Revenue Market Share by Region (2017-2022)
Table 45. APAC Oral Anticoagulants Sales by Type (2017-2022) & (K Units)
Table 46. APAC Oral Anticoagulants Sales Market Share by Type (2017-2022)
Table 47. APAC Oral Anticoagulants Sales by Application (2017-2022) & (K Units)
Table 48. APAC Oral Anticoagulants Sales Market Share by Application (2017-2022)
Table 49. Europe Oral Anticoagulants Sales by Country (2017-2022) & (K Units)
Table 50. Europe Oral Anticoagulants Sales Market Share by Country (2017-2022)
Table 51. Europe Oral Anticoagulants Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Oral Anticoagulants Revenue Market Share by Country (2017-2022)
Table 53. Europe Oral Anticoagulants Sales by Type (2017-2022) & (K Units)
Table 54. Europe Oral Anticoagulants Sales Market Share by Type (2017-2022)
Table 55. Europe Oral Anticoagulants Sales by Application (2017-2022) & (K Units)
Table 56. Europe Oral Anticoagulants Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Oral Anticoagulants Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Oral Anticoagulants Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Oral Anticoagulants Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Oral Anticoagulants Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Oral Anticoagulants Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Oral Anticoagulants Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Oral Anticoagulants Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Oral Anticoagulants Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Oral Anticoagulants
Table 66. Key Market Challenges & Risks of Oral Anticoagulants
Table 67. Key Industry Trends of Oral Anticoagulants
Table 68. Oral Anticoagulants Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Oral Anticoagulants Distributors List
Table 71. Oral Anticoagulants Customer List
Table 72. Global Oral Anticoagulants Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Oral Anticoagulants Sales Market Forecast by Region
Table 74. Global Oral Anticoagulants Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Oral Anticoagulants Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Oral Anticoagulants Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Oral Anticoagulants Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Oral Anticoagulants Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Oral Anticoagulants Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Oral Anticoagulants Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Oral Anticoagulants Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Oral Anticoagulants Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Oral Anticoagulants Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Oral Anticoagulants Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Oral Anticoagulants Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Oral Anticoagulants Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Oral Anticoagulants Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Oral Anticoagulants Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Oral Anticoagulants Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Oral Anticoagulants Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Oral Anticoagulants Revenue Market Share Forecast by Application (2023-2028)
Table 92. Johnson & Johnson Basic Information, Oral Anticoagulants Manufacturing Base, Sales Area and Its Competitors
Table 93. Johnson & Johnson Oral Anticoagulants Product Offered
Table 94. Johnson & Johnson Oral Anticoagulants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. Johnson & Johnson Main Business
Table 96. Johnson & Johnson Latest Developments
Table 97. Bristol-Myers Squibb Basic Information, Oral Anticoagulants Manufacturing Base, Sales Area and Its Competitors
Table 98. Bristol-Myers Squibb Oral Anticoagulants Product Offered
Table 99. Bristol-Myers Squibb Oral Anticoagulants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 100. Bristol-Myers Squibb Main Business
Table 101. Bristol-Myers Squibb Latest Developments
Table 102. Boehringer Ingelheim Basic Information, Oral Anticoagulants Manufacturing Base, Sales Area and Its Competitors
Table 103. Boehringer Ingelheim Oral Anticoagulants Product Offered
Table 104. Boehringer Ingelheim Oral Anticoagulants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 105. Boehringer Ingelheim Main Business
Table 106. Boehringer Ingelheim Latest Developments
Table 107. Sanofi Basic Information, Oral Anticoagulants Manufacturing Base, Sales Area and Its Competitors
Table 108. Sanofi Oral Anticoagulants Product Offered
Table 109. Sanofi Oral Anticoagulants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 110. Sanofi Main Business
Table 111. Sanofi Latest Developments
Table 112. Daiichi Sankyo Basic Information, Oral Anticoagulants Manufacturing Base, Sales Area and Its Competitors
Table 113. Daiichi Sankyo Oral Anticoagulants Product Offered
Table 114. Daiichi Sankyo Oral Anticoagulants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 115. Daiichi Sankyo Main Business
Table 116. Daiichi Sankyo Latest Developments
Table 117. Armatheon Basic Information, Oral Anticoagulants Manufacturing Base, Sales Area and Its Competitors
Table 118. Armatheon Oral Anticoagulants Product Offered
Table 119. Armatheon Oral Anticoagulants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 120. Armatheon Main Business
Table 121. Armatheon Latest Developments
Table 122. Aspen Basic Information, Oral Anticoagulants Manufacturing Base, Sales Area and Its Competitors
Table 123. Aspen Oral Anticoagulants Product Offered
Table 124. Aspen Oral Anticoagulants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 125. Aspen Main Business
Table 126. Aspen Latest Developments
Table 127. AstraZeneca Basic Information, Oral Anticoagulants Manufacturing Base, Sales Area and Its Competitors
Table 128. AstraZeneca Oral Anticoagulants Product Offered
Table 129. AstraZeneca Oral Anticoagulants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 130. AstraZeneca Main Business
Table 131. AstraZeneca Latest Developments
Table 132. Bayer Basic Information, Oral Anticoagulants Manufacturing Base, Sales Area and Its Competitors
Table 133. Bayer Oral Anticoagulants Product Offered
Table 134. Bayer Oral Anticoagulants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 135. Bayer Main Business
Table 136. Bayer Latest Developments
Table 137. Cellceutix Basic Information, Oral Anticoagulants Manufacturing Base, Sales Area and Its Competitors
Table 138. Cellceutix Oral Anticoagulants Product Offered
Table 139. Cellceutix Oral Anticoagulants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 140. Cellceutix Main Business
Table 141. Cellceutix Latest Developments
Table 142. Cosmo Pharmaceuticals Basic Information, Oral Anticoagulants Manufacturing Base, Sales Area and Its Competitors
Table 143. Cosmo Pharmaceuticals Oral Anticoagulants Product Offered
Table 144. Cosmo Pharmaceuticals Oral Anticoagulants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 145. Cosmo Pharmaceuticals Main Business
Table 146. Cosmo Pharmaceuticals Latest Developments
Table 147. CSL Behring Basic Information, Oral Anticoagulants Manufacturing Base, Sales Area and Its Competitors
Table 148. CSL Behring Oral Anticoagulants Product Offered
Table 149. CSL Behring Oral Anticoagulants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 150. CSL Behring Main Business
Table 151. CSL Behring Latest Developments
Table 152. Eisai Basic Information, Oral Anticoagulants Manufacturing Base, Sales Area and Its Competitors
Table 153. Eisai Oral Anticoagulants Product Offered
Table 154. Eisai Oral Anticoagulants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 155. Eisai Main Business
Table 156. Eisai Latest Developments
Table 157. GSK Basic Information, Oral Anticoagulants Manufacturing Base, Sales Area and Its Competitors
Table 158. GSK Oral Anticoagulants Product Offered
Table 159. GSK Oral Anticoagulants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 160. GSK Main Business
Table 161. GSK Latest Developments
Table 162. Marathon Pharmaceuticals Basic Information, Oral Anticoagulants Manufacturing Base, Sales Area and Its Competitors
Table 163. Marathon Pharmaceuticals Oral Anticoagulants Product Offered
Table 164. Marathon Pharmaceuticals Oral Anticoagulants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 165. Marathon Pharmaceuticals Main Business
Table 166. Marathon Pharmaceuticals Latest Developments
Table 167. Ockham Biotech Basic Information, Oral Anticoagulants Manufacturing Base, Sales Area and Its Competitors
Table 168. Ockham Biotech Oral Anticoagulants Product Offered
Table 169. Ockham Biotech Oral Anticoagulants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 170. Ockham Biotech Main Business
Table 171. Ockham Biotech Latest Developments
Table 172. Perosphere Basic Information, Oral Anticoagulants Manufacturing Base, Sales Area and Its Competitors
Table 173. Perosphere Oral Anticoagulants Product Offered
Table 174. Perosphere Oral Anticoagulants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 175. Perosphere Main Business
Table 176. Perosphere Latest Developments
Table 1. Oral Anticoagulants Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Oral Anticoagulants Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Direct Thrombin Inhibitors
Table 4. Major Players of Direct Factor Xa Inhibitors
Table 5. Global Oral Anticoagulants Sales by Type (2017-2022) & (K Units)
Table 6. Global Oral Anticoagulants Sales Market Share by Type (2017-2022)
Table 7. Global Oral Anticoagulants Revenue by Type (2017-2022) & ($ million)
Table 8. Global Oral Anticoagulants Revenue Market Share by Type (2017-2022)
Table 9. Global Oral Anticoagulants Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Oral Anticoagulants Sales by Application (2017-2022) & (K Units)
Table 11. Global Oral Anticoagulants Sales Market Share by Application (2017-2022)
Table 12. Global Oral Anticoagulants Revenue by Application (2017-2022)
Table 13. Global Oral Anticoagulants Revenue Market Share by Application (2017-2022)
Table 14. Global Oral Anticoagulants Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Oral Anticoagulants Sales by Company (2020-2022) & (K Units)
Table 16. Global Oral Anticoagulants Sales Market Share by Company (2020-2022)
Table 17. Global Oral Anticoagulants Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Oral Anticoagulants Revenue Market Share by Company (2020-2022)
Table 19. Global Oral Anticoagulants Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Oral Anticoagulants Producing Area Distribution and Sales Area
Table 21. Players Oral Anticoagulants Products Offered
Table 22. Oral Anticoagulants Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Oral Anticoagulants Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Oral Anticoagulants Sales Market Share Geographic Region (2017-2022)
Table 27. Global Oral Anticoagulants Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Oral Anticoagulants Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Oral Anticoagulants Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Oral Anticoagulants Sales Market Share by Country/Region (2017-2022)
Table 31. Global Oral Anticoagulants Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Oral Anticoagulants Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Oral Anticoagulants Sales by Country (2017-2022) & (K Units)
Table 34. Americas Oral Anticoagulants Sales Market Share by Country (2017-2022)
Table 35. Americas Oral Anticoagulants Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Oral Anticoagulants Revenue Market Share by Country (2017-2022)
Table 37. Americas Oral Anticoagulants Sales by Type (2017-2022) & (K Units)
Table 38. Americas Oral Anticoagulants Sales Market Share by Type (2017-2022)
Table 39. Americas Oral Anticoagulants Sales by Application (2017-2022) & (K Units)
Table 40. Americas Oral Anticoagulants Sales Market Share by Application (2017-2022)
Table 41. APAC Oral Anticoagulants Sales by Region (2017-2022) & (K Units)
Table 42. APAC Oral Anticoagulants Sales Market Share by Region (2017-2022)
Table 43. APAC Oral Anticoagulants Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Oral Anticoagulants Revenue Market Share by Region (2017-2022)
Table 45. APAC Oral Anticoagulants Sales by Type (2017-2022) & (K Units)
Table 46. APAC Oral Anticoagulants Sales Market Share by Type (2017-2022)
Table 47. APAC Oral Anticoagulants Sales by Application (2017-2022) & (K Units)
Table 48. APAC Oral Anticoagulants Sales Market Share by Application (2017-2022)
Table 49. Europe Oral Anticoagulants Sales by Country (2017-2022) & (K Units)
Table 50. Europe Oral Anticoagulants Sales Market Share by Country (2017-2022)
Table 51. Europe Oral Anticoagulants Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Oral Anticoagulants Revenue Market Share by Country (2017-2022)
Table 53. Europe Oral Anticoagulants Sales by Type (2017-2022) & (K Units)
Table 54. Europe Oral Anticoagulants Sales Market Share by Type (2017-2022)
Table 55. Europe Oral Anticoagulants Sales by Application (2017-2022) & (K Units)
Table 56. Europe Oral Anticoagulants Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Oral Anticoagulants Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Oral Anticoagulants Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Oral Anticoagulants Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Oral Anticoagulants Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Oral Anticoagulants Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Oral Anticoagulants Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Oral Anticoagulants Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Oral Anticoagulants Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Oral Anticoagulants
Table 66. Key Market Challenges & Risks of Oral Anticoagulants
Table 67. Key Industry Trends of Oral Anticoagulants
Table 68. Oral Anticoagulants Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Oral Anticoagulants Distributors List
Table 71. Oral Anticoagulants Customer List
Table 72. Global Oral Anticoagulants Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Oral Anticoagulants Sales Market Forecast by Region
Table 74. Global Oral Anticoagulants Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Oral Anticoagulants Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Oral Anticoagulants Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Oral Anticoagulants Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Oral Anticoagulants Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Oral Anticoagulants Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Oral Anticoagulants Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Oral Anticoagulants Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Oral Anticoagulants Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Oral Anticoagulants Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Oral Anticoagulants Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Oral Anticoagulants Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Oral Anticoagulants Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Oral Anticoagulants Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Oral Anticoagulants Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Oral Anticoagulants Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Oral Anticoagulants Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Oral Anticoagulants Revenue Market Share Forecast by Application (2023-2028)
Table 92. Johnson & Johnson Basic Information, Oral Anticoagulants Manufacturing Base, Sales Area and Its Competitors
Table 93. Johnson & Johnson Oral Anticoagulants Product Offered
Table 94. Johnson & Johnson Oral Anticoagulants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. Johnson & Johnson Main Business
Table 96. Johnson & Johnson Latest Developments
Table 97. Bristol-Myers Squibb Basic Information, Oral Anticoagulants Manufacturing Base, Sales Area and Its Competitors
Table 98. Bristol-Myers Squibb Oral Anticoagulants Product Offered
Table 99. Bristol-Myers Squibb Oral Anticoagulants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 100. Bristol-Myers Squibb Main Business
Table 101. Bristol-Myers Squibb Latest Developments
Table 102. Boehringer Ingelheim Basic Information, Oral Anticoagulants Manufacturing Base, Sales Area and Its Competitors
Table 103. Boehringer Ingelheim Oral Anticoagulants Product Offered
Table 104. Boehringer Ingelheim Oral Anticoagulants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 105. Boehringer Ingelheim Main Business
Table 106. Boehringer Ingelheim Latest Developments
Table 107. Sanofi Basic Information, Oral Anticoagulants Manufacturing Base, Sales Area and Its Competitors
Table 108. Sanofi Oral Anticoagulants Product Offered
Table 109. Sanofi Oral Anticoagulants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 110. Sanofi Main Business
Table 111. Sanofi Latest Developments
Table 112. Daiichi Sankyo Basic Information, Oral Anticoagulants Manufacturing Base, Sales Area and Its Competitors
Table 113. Daiichi Sankyo Oral Anticoagulants Product Offered
Table 114. Daiichi Sankyo Oral Anticoagulants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 115. Daiichi Sankyo Main Business
Table 116. Daiichi Sankyo Latest Developments
Table 117. Armatheon Basic Information, Oral Anticoagulants Manufacturing Base, Sales Area and Its Competitors
Table 118. Armatheon Oral Anticoagulants Product Offered
Table 119. Armatheon Oral Anticoagulants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 120. Armatheon Main Business
Table 121. Armatheon Latest Developments
Table 122. Aspen Basic Information, Oral Anticoagulants Manufacturing Base, Sales Area and Its Competitors
Table 123. Aspen Oral Anticoagulants Product Offered
Table 124. Aspen Oral Anticoagulants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 125. Aspen Main Business
Table 126. Aspen Latest Developments
Table 127. AstraZeneca Basic Information, Oral Anticoagulants Manufacturing Base, Sales Area and Its Competitors
Table 128. AstraZeneca Oral Anticoagulants Product Offered
Table 129. AstraZeneca Oral Anticoagulants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 130. AstraZeneca Main Business
Table 131. AstraZeneca Latest Developments
Table 132. Bayer Basic Information, Oral Anticoagulants Manufacturing Base, Sales Area and Its Competitors
Table 133. Bayer Oral Anticoagulants Product Offered
Table 134. Bayer Oral Anticoagulants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 135. Bayer Main Business
Table 136. Bayer Latest Developments
Table 137. Cellceutix Basic Information, Oral Anticoagulants Manufacturing Base, Sales Area and Its Competitors
Table 138. Cellceutix Oral Anticoagulants Product Offered
Table 139. Cellceutix Oral Anticoagulants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 140. Cellceutix Main Business
Table 141. Cellceutix Latest Developments
Table 142. Cosmo Pharmaceuticals Basic Information, Oral Anticoagulants Manufacturing Base, Sales Area and Its Competitors
Table 143. Cosmo Pharmaceuticals Oral Anticoagulants Product Offered
Table 144. Cosmo Pharmaceuticals Oral Anticoagulants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 145. Cosmo Pharmaceuticals Main Business
Table 146. Cosmo Pharmaceuticals Latest Developments
Table 147. CSL Behring Basic Information, Oral Anticoagulants Manufacturing Base, Sales Area and Its Competitors
Table 148. CSL Behring Oral Anticoagulants Product Offered
Table 149. CSL Behring Oral Anticoagulants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 150. CSL Behring Main Business
Table 151. CSL Behring Latest Developments
Table 152. Eisai Basic Information, Oral Anticoagulants Manufacturing Base, Sales Area and Its Competitors
Table 153. Eisai Oral Anticoagulants Product Offered
Table 154. Eisai Oral Anticoagulants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 155. Eisai Main Business
Table 156. Eisai Latest Developments
Table 157. GSK Basic Information, Oral Anticoagulants Manufacturing Base, Sales Area and Its Competitors
Table 158. GSK Oral Anticoagulants Product Offered
Table 159. GSK Oral Anticoagulants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 160. GSK Main Business
Table 161. GSK Latest Developments
Table 162. Marathon Pharmaceuticals Basic Information, Oral Anticoagulants Manufacturing Base, Sales Area and Its Competitors
Table 163. Marathon Pharmaceuticals Oral Anticoagulants Product Offered
Table 164. Marathon Pharmaceuticals Oral Anticoagulants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 165. Marathon Pharmaceuticals Main Business
Table 166. Marathon Pharmaceuticals Latest Developments
Table 167. Ockham Biotech Basic Information, Oral Anticoagulants Manufacturing Base, Sales Area and Its Competitors
Table 168. Ockham Biotech Oral Anticoagulants Product Offered
Table 169. Ockham Biotech Oral Anticoagulants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 170. Ockham Biotech Main Business
Table 171. Ockham Biotech Latest Developments
Table 172. Perosphere Basic Information, Oral Anticoagulants Manufacturing Base, Sales Area and Its Competitors
Table 173. Perosphere Oral Anticoagulants Product Offered
Table 174. Perosphere Oral Anticoagulants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 175. Perosphere Main Business
Table 176. Perosphere Latest Developments
LIST OF FIGURES
Figure 1. Picture of Oral Anticoagulants
Figure 2. Oral Anticoagulants Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oral Anticoagulants Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Oral Anticoagulants Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Oral Anticoagulants Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Direct Thrombin Inhibitors
Figure 10. Product Picture of Direct Factor Xa Inhibitors
Figure 11. Global Oral Anticoagulants Sales Market Share by Type in 2021
Figure 12. Global Oral Anticoagulants Revenue Market Share by Type (2017-2022)
Figure 13. Oral Anticoagulants Consumed in Deep Vein Thrombosis (DVT)
Figure 14. Global Oral Anticoagulants Market: Deep Vein Thrombosis (DVT) (2017-2022) & (K Units)
Figure 15. Oral Anticoagulants Consumed in Pulmonary Embolism
Figure 16. Global Oral Anticoagulants Market: Pulmonary Embolism (2017-2022) & (K Units)
Figure 17. Oral Anticoagulants Consumed in Acute Coronary Syndrome
Figure 18. Global Oral Anticoagulants Market: Acute Coronary Syndrome (2017-2022) & (K Units)
Figure 19. Oral Anticoagulants Consumed in Hemodialysis
Figure 20. Global Oral Anticoagulants Market: Hemodialysis (2017-2022) & (K Units)
Figure 21. Oral Anticoagulants Consumed in Others
Figure 22. Global Oral Anticoagulants Market: Others (2017-2022) & (K Units)
Figure 23. Global Oral Anticoagulants Sales Market Share by Application (2017-2022)
Figure 24. Global Oral Anticoagulants Revenue Market Share by Application in 2021
Figure 25. Oral Anticoagulants Revenue Market by Company in 2021 ($ Million)
Figure 26. Global Oral Anticoagulants Revenue Market Share by Company in 2021
Figure 27. Global Oral Anticoagulants Sales Market Share by Geographic Region (2017-2022)
Figure 28. Global Oral Anticoagulants Revenue Market Share by Geographic Region in 2021
Figure 29. Global Oral Anticoagulants Sales Market Share by Region (2017-2022)
Figure 30. Global Oral Anticoagulants Revenue Market Share by Country/Region in 2021
Figure 31. Americas Oral Anticoagulants Sales 2017-2022 (K Units)
Figure 32. Americas Oral Anticoagulants Revenue 2017-2022 ($ Millions)
Figure 33. APAC Oral Anticoagulants Sales 2017-2022 (K Units)
Figure 34. APAC Oral Anticoagulants Revenue 2017-2022 ($ Millions)
Figure 35. Europe Oral Anticoagulants Sales 2017-2022 (K Units)
Figure 36. Europe Oral Anticoagulants Revenue 2017-2022 ($ Millions)
Figure 37. Middle East & Africa Oral Anticoagulants Sales 2017-2022 (K Units)
Figure 38. Middle East & Africa Oral Anticoagulants Revenue 2017-2022 ($ Millions)
Figure 39. Americas Oral Anticoagulants Sales Market Share by Country in 2021
Figure 40. Americas Oral Anticoagulants Revenue Market Share by Country in 2021
Figure 41. United States Oral Anticoagulants Revenue Growth 2017-2022 ($ Millions)
Figure 42. Canada Oral Anticoagulants Revenue Growth 2017-2022 ($ Millions)
Figure 43. Mexico Oral Anticoagulants Revenue Growth 2017-2022 ($ Millions)
Figure 44. Brazil Oral Anticoagulants Revenue Growth 2017-2022 ($ Millions)
Figure 45. APAC Oral Anticoagulants Sales Market Share by Region in 2021
Figure 46. APAC Oral Anticoagulants Revenue Market Share by Regions in 2021
Figure 47. China Oral Anticoagulants Revenue Growth 2017-2022 ($ Millions)
Figure 48. Japan Oral Anticoagulants Revenue Growth 2017-2022 ($ Millions)
Figure 49. South Korea Oral Anticoagulants Revenue Growth 2017-2022 ($ Millions)
Figure 50. Southeast Asia Oral Anticoagulants Revenue Growth 2017-2022 ($ Millions)
Figure 51. India Oral Anticoagulants Revenue Growth 2017-2022 ($ Millions)
Figure 52. Australia Oral Anticoagulants Revenue Growth 2017-2022 ($ Millions)
Figure 53. Europe Oral Anticoagulants Sales Market Share by Country in 2021
Figure 54. Europe Oral Anticoagulants Revenue Market Share by Country in 2021
Figure 55. Germany Oral Anticoagulants Revenue Growth 2017-2022 ($ Millions)
Figure 56. France Oral Anticoagulants Revenue Growth 2017-2022 ($ Millions)
Figure 57. UK Oral Anticoagulants Revenue Growth 2017-2022 ($ Millions)
Figure 58. Italy Oral Anticoagulants Revenue Growth 2017-2022 ($ Millions)
Figure 59. Russia Oral Anticoagulants Revenue Growth 2017-2022 ($ Millions)
Figure 60. Middle East & Africa Oral Anticoagulants Sales Market Share by Country in 2021
Figure 61. Middle East & Africa Oral Anticoagulants Revenue Market Share by Country in 2021
Figure 62. Egypt Oral Anticoagulants Revenue Growth 2017-2022 ($ Millions)
Figure 63. South Africa Oral Anticoagulants Revenue Growth 2017-2022 ($ Millions)
Figure 64. Israel Oral Anticoagulants Revenue Growth 2017-2022 ($ Millions)
Figure 65. Turkey Oral Anticoagulants Revenue Growth 2017-2022 ($ Millions)
Figure 66. GCC Country Oral Anticoagulants Revenue Growth 2017-2022 ($ Millions)
Figure 67. Manufacturing Cost Structure Analysis of Oral Anticoagulants in 2021
Figure 68. Manufacturing Process Analysis of Oral Anticoagulants
Figure 69. Industry Chain Structure of Oral Anticoagulants
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
Figure 1. Picture of Oral Anticoagulants
Figure 2. Oral Anticoagulants Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oral Anticoagulants Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Oral Anticoagulants Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Oral Anticoagulants Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Direct Thrombin Inhibitors
Figure 10. Product Picture of Direct Factor Xa Inhibitors
Figure 11. Global Oral Anticoagulants Sales Market Share by Type in 2021
Figure 12. Global Oral Anticoagulants Revenue Market Share by Type (2017-2022)
Figure 13. Oral Anticoagulants Consumed in Deep Vein Thrombosis (DVT)
Figure 14. Global Oral Anticoagulants Market: Deep Vein Thrombosis (DVT) (2017-2022) & (K Units)
Figure 15. Oral Anticoagulants Consumed in Pulmonary Embolism
Figure 16. Global Oral Anticoagulants Market: Pulmonary Embolism (2017-2022) & (K Units)
Figure 17. Oral Anticoagulants Consumed in Acute Coronary Syndrome
Figure 18. Global Oral Anticoagulants Market: Acute Coronary Syndrome (2017-2022) & (K Units)
Figure 19. Oral Anticoagulants Consumed in Hemodialysis
Figure 20. Global Oral Anticoagulants Market: Hemodialysis (2017-2022) & (K Units)
Figure 21. Oral Anticoagulants Consumed in Others
Figure 22. Global Oral Anticoagulants Market: Others (2017-2022) & (K Units)
Figure 23. Global Oral Anticoagulants Sales Market Share by Application (2017-2022)
Figure 24. Global Oral Anticoagulants Revenue Market Share by Application in 2021
Figure 25. Oral Anticoagulants Revenue Market by Company in 2021 ($ Million)
Figure 26. Global Oral Anticoagulants Revenue Market Share by Company in 2021
Figure 27. Global Oral Anticoagulants Sales Market Share by Geographic Region (2017-2022)
Figure 28. Global Oral Anticoagulants Revenue Market Share by Geographic Region in 2021
Figure 29. Global Oral Anticoagulants Sales Market Share by Region (2017-2022)
Figure 30. Global Oral Anticoagulants Revenue Market Share by Country/Region in 2021
Figure 31. Americas Oral Anticoagulants Sales 2017-2022 (K Units)
Figure 32. Americas Oral Anticoagulants Revenue 2017-2022 ($ Millions)
Figure 33. APAC Oral Anticoagulants Sales 2017-2022 (K Units)
Figure 34. APAC Oral Anticoagulants Revenue 2017-2022 ($ Millions)
Figure 35. Europe Oral Anticoagulants Sales 2017-2022 (K Units)
Figure 36. Europe Oral Anticoagulants Revenue 2017-2022 ($ Millions)
Figure 37. Middle East & Africa Oral Anticoagulants Sales 2017-2022 (K Units)
Figure 38. Middle East & Africa Oral Anticoagulants Revenue 2017-2022 ($ Millions)
Figure 39. Americas Oral Anticoagulants Sales Market Share by Country in 2021
Figure 40. Americas Oral Anticoagulants Revenue Market Share by Country in 2021
Figure 41. United States Oral Anticoagulants Revenue Growth 2017-2022 ($ Millions)
Figure 42. Canada Oral Anticoagulants Revenue Growth 2017-2022 ($ Millions)
Figure 43. Mexico Oral Anticoagulants Revenue Growth 2017-2022 ($ Millions)
Figure 44. Brazil Oral Anticoagulants Revenue Growth 2017-2022 ($ Millions)
Figure 45. APAC Oral Anticoagulants Sales Market Share by Region in 2021
Figure 46. APAC Oral Anticoagulants Revenue Market Share by Regions in 2021
Figure 47. China Oral Anticoagulants Revenue Growth 2017-2022 ($ Millions)
Figure 48. Japan Oral Anticoagulants Revenue Growth 2017-2022 ($ Millions)
Figure 49. South Korea Oral Anticoagulants Revenue Growth 2017-2022 ($ Millions)
Figure 50. Southeast Asia Oral Anticoagulants Revenue Growth 2017-2022 ($ Millions)
Figure 51. India Oral Anticoagulants Revenue Growth 2017-2022 ($ Millions)
Figure 52. Australia Oral Anticoagulants Revenue Growth 2017-2022 ($ Millions)
Figure 53. Europe Oral Anticoagulants Sales Market Share by Country in 2021
Figure 54. Europe Oral Anticoagulants Revenue Market Share by Country in 2021
Figure 55. Germany Oral Anticoagulants Revenue Growth 2017-2022 ($ Millions)
Figure 56. France Oral Anticoagulants Revenue Growth 2017-2022 ($ Millions)
Figure 57. UK Oral Anticoagulants Revenue Growth 2017-2022 ($ Millions)
Figure 58. Italy Oral Anticoagulants Revenue Growth 2017-2022 ($ Millions)
Figure 59. Russia Oral Anticoagulants Revenue Growth 2017-2022 ($ Millions)
Figure 60. Middle East & Africa Oral Anticoagulants Sales Market Share by Country in 2021
Figure 61. Middle East & Africa Oral Anticoagulants Revenue Market Share by Country in 2021
Figure 62. Egypt Oral Anticoagulants Revenue Growth 2017-2022 ($ Millions)
Figure 63. South Africa Oral Anticoagulants Revenue Growth 2017-2022 ($ Millions)
Figure 64. Israel Oral Anticoagulants Revenue Growth 2017-2022 ($ Millions)
Figure 65. Turkey Oral Anticoagulants Revenue Growth 2017-2022 ($ Millions)
Figure 66. GCC Country Oral Anticoagulants Revenue Growth 2017-2022 ($ Millions)
Figure 67. Manufacturing Cost Structure Analysis of Oral Anticoagulants in 2021
Figure 68. Manufacturing Process Analysis of Oral Anticoagulants
Figure 69. Industry Chain Structure of Oral Anticoagulants
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
